CGS
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Cogstate Limited is a neuroscience solutions company that provides digital cognitive assessment tools and electronic clinical outcome assessment (eCOA) services. The company supports biopharmaceutical companies, academic institutions, and clinical care providers by offering valid and sensitive measures of cognition for clinical trials and patient monitoring. Its business segments include digital cognitive assessment, endpoint data quality assurance through rater training and central monitoring, remote assessment for decentralized trials, and healthcare cognitive screening. Cogstate serves markets in sports medicine, where it assesses concussive injury, and in the development of therapeutics for conditions such as depression, schizophrenia, and bipolar disorder. Founded in 1999 by neuroscientists in Australia, the company operates a global network of experts in psychology, neuropsychology, psychiatry, and neurology to support research projects worldwide.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Health Care Equipment & Services Homepage cogstate.com
Sector Healthcare IR page investors.cogstate.com
Tags
cognitive assessment, clinical trials, neuroscience, ecoa, rater training, sports medicine, decentralized trials, cognitive screening
Press page cogstate.com/news

Metrics

Valuation  
Market cap A$ 649.075M
Market cap (USD) $ 440.421M
P/E 35.39
PEG 0.72
P/BV 7.22
P/S 13.94
P/OCF 53.58
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 22.4%
ROI 20.4%
ROIC 20.4%
Profit margin 20.3%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 49.4%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 58.586M 50.813M 39.722M 36.263M 44.98M 32.686M 22.771M 21.834M 28.957M 26.405M 19.638M 12.647M 10.158M 12.946M 12.675M 8.288M 7.355M
Net profit 11.895M 10.145M 5.45M 3.568M 7.52M 5.233M -1.957M -2.496M -565.918K -643.339K 1.904M -3.983M -3.487M -2.033M 2.587M -850.333K -765.209K

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 1.73 — — — — — — — — — — — — — — — —
P/OCF 34.69 — — — — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

ASX:CGS - Change of Director's Interest Notice - BOC Bull 0 Bear 0 Routine

Logo

Cogstate Investor Hub

Log in Sign up

Home

Company

Board of Directors Corporate Governance

Why Invest Investor Insight Series Shareholder Day

Announcements

ASX Announcements Investor Presentations Annual Reports Financial Calendar

Shareholders

Share Price Shareholder Information

Updates

Back to Cogstate Ltd

Change of Director's Interest Notice - BOC

Released 29 Oct 2026 - 1:16 AM

Released 29 Oct 2026 - 1:16 AM

LikeFollowShare

Announcement PDF Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Cogstate Limited ABN 80 090 975 723 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Bradley O’Connor Date of last notice 3 November 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest 1. Direct 2. Direct 3. Indirect 4. Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. 1. N/A 2. N/A 3. As beneficiary of O’Connor Superannuation Fund, registered holder: Ronnocob Pty Ltd <O’Connor Superannuation Fund A/C> 4. N/A Date of change 26 October 2026 – Exercise of Options 29 October 2026 – Sale of Shares No. of securities held prior to change 1. Ordinary Shares: 5,400,000 2. Employee Options: 500,000 3. Ordinary Shares: 1,000,000 4. Performance Rights: 1,512,073 Class 1. Ordinary Shares 2. Employee Options 3. Ordinary Shares 4. Performance Rights Number acquired 1. 500,000 2. Nil 3. Nil 4. Nil Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Number disposed 1. 500,000 2. 500,000 3. Nil 4. Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation 1. $1,656,223 sales proceeds 2. $1,189,500 exercise cost 3. N/A 4. N/A No. of securities held after change 1. Ordinary Shares: 5,400,000 2. Employee Options: Nil 3. Ordinary Shares: 1,000,000 4. Performance Rights: 1,512,073 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back 1. 500,000 shares sold on market at $3.34 per share (excl. brokerage) 2. 500,000 options exercised at $2.379 per share 3. N/A 4. N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A

Open panelView summary and Q&As

Share your feedback

Questions (0)

Post question

Your question will be sent privately to Cogstate Ltd. The company may choose to make this question public.


Start the conversation

Ask Cogstate Ltd a question about this announcement.

Discover

Summary

Summary

Questions (0)

Post question

Your question will be sent privately to Cogstate Ltd. The company may choose to make this question public.


Start the conversation

Ask Cogstate Ltd a question about this announcement.

Share your feedback

Discover

Prompts

Cogstate Limited (ticker CGS), listed in Australia.

Company History

Date Change Detail
Jun 30, 2016 Reporting currency Its AU reports are in USD instead of AUD from this period. Earlier figures are shown in USD, converted at each period end's exchange rate.

ETFs Holding Cogstate Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.01% 14,117 $ 33.68K Nov 16, 2026
DFSI 0.00% 60 $ 153.63 Nov 12, 2026